Ionis Pharmaceuticals, Inc. IONS
$73.14
โผ -0.73% 24H
About
Ionis Pharmaceuticals, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of human therapeutics using antisense technology. This proprietary platform enables the creation of novel drugs targeting difficult-to-treat diseases across cardiovascular, metabolic, neurological, aโฆ
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,402
TickerIONS
Statistics
Market Cap$12.13B
Revenue (TTM)$943.7M
Net Income-$381.4M
Net Margin-40.4%
EPS$-2.01
P/E-31.01
P/S11.53
P/B24.92
EV/EBITDA-37.65
ROE-67.6%
Dividend Yieldโ
Price$73.14
Data: Twelve Data ยท Revenue = mcap / P/S